Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
EJNMMI Radiopharmacy and Chemistry|March 26, 2026
Highlight selection of radiochemistry and radiopharmacy developments by editorial boardOliver C Kiss, Ivan Penuelas, Ana Rey, et al.Nature|August 26, 2021
A clinically applicable integrative molecular classification of meningiomasFarshad Nassiri, Jeff Liu, Vikas Patil, et al.Neuro-Oncology|November 19, 2025
A framework for using DNA methylation-based modelling for the clinical management of cranial meningiomaAlexander P Landry, Justin Z Wang, Vikas Patil, et al.The Lancet. Oncology|September 4, 2025
Analysis of TERT association with clinical outcome in meningiomas: a multi-institutional cohort studyChloe Gui, Justin Z Wang, Vikas Patil, et al.ACS Nano|April 8, 2020
Nanoparticle Uptake in a Spontaneous and Immunocompetent Woodchuck Liver Cancer ModelLewis Y Liu, Xue-Zhong Ma, Ben Ouyang, et al.Plos Genetics|July 14, 2012
Meta-analysis of genome-wide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locusCarolina Medina-Gomez, John P Kemp, Karol Estrada, et al.Neuro-Oncology|January 8, 2025
Development and validation of a molecular classifier of meningiomasAlexander P Landry, Justin Z Wang, Jeff Liu, et al.Neuro-Oncology|November 9, 2025
Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights the Need for Lifespan Precision in Neuro-OncologyLeeor S Yefet, Alexander P Landry, Justin Z Wang, et al.JAMA Oncology|April 3, 2025
Chromosome 1p Loss and 1q Gain for Grading of MeningiomaAlexander P Landry, Justin Z Wang, Vikas Patil, et al.Neuro-Oncology|May 17, 2026
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant MeningiomasLeeor S Yefet, Alexander P Landry, C Leland Rogers, et al.Pageof 5